@keryx.com
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
About
Description
Keryx Biopharmaceuticals is a fully integrated renal biopharmaceutical company that aims to address complications of kidney disease. They are a trusted leader in the renal community, offering unique products to individuals with kidney disease. Their portfolio includes a commercially available medicine, VAFSEO® (vadadustat), which is approved for use in 34 countries.
They also have a late stage product in global Phase 3 clinical development, vadadustat, which is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) based on Nobel Prize-winning science. By advancing new hope and challenging the status quo, Keryx Biopharmaceuticals strives to make a difference in the lives of those with kidney disease. Join their passionate team in their research and development efforts to protect the kidneys and innovate for better lives.
Learn more about their mission and products by visiting their website
Company Size
2-10
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online